Defective Drugs
Takeda Ordered to Pay Over $2 Million to Actos Patient
Hip Implant Systems Not Adequately Tested
Blue Shield and Blue Cross File Claim Over Actos
Jury Awards $9 Billion after an Actos Trial
Possible Settlement for NuvaRing Lawsuits
FDA Begins Regulating Apps
Verdict Reached in First Actos Trial
More Trouble for Maker of Diabetes Drug Actos
FDA Approval Process Allows Defective Devices to Slip Through the Cracks
Consumer Reports Investigates Dangerous Medical Devices and the FDA’s Failure to Protect Consumers from Defective Products
FDA Scheduled to Hold Meeting on Metal-on-Metal Hip Devices this Summer
FDA’s Process for Approving Medical Devices under Review